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Abstract
Introduction Patients after out-of-hospital cardiac arrest
(OHCA) benefit from therapeutic hypothermia for 24 hours. The
time needed to reach hypothermia (target temperature of 32°C
to 34°C) varies widely. In this study, we explore the relation
between measures of body composition and the time needed to
reach target temperature with hypothermia.
Method We conducted a prospective observational study in
patients treated with hypothermia after OHCA. Data collected
included weight and height, body composition by
anthropometric measures and by single-frequency body
impedance, and waist-to-hip ratio. Analysis of concordance
between impedance and anthropometric measures and hazard
ratios of achieving target temperature (event) corrected for
different body composition measures.
Results Twenty-seven patients were included. The median
(interquartile range) time to reach target temperature after
admission to the intensive care unit was 191 (105 to 382)
minutes. Intraclass correlation for total body fat (TBF) measures
was 0.94 (95% confidence interval [CI] 0.89 to 0.97). Only TBF
percentage (anthropometrics by the Durnin's table) appeared to
be associated with time to reach target temperature: 0.93 (95%
CI 0.87 to 0.99; P = 0.03).
Conclusion The body composition measures from single-
frequency impedance and anthropometrics appear to be very
concordant. Only TBF percentage (anthropometrics) showed a
significant but clinically irrelevant influence on time needed to
achieve target temperature with hypothermia. We conclude that
there are no indications to adjust current cooling practice
toward the body composition of patients.
Introduction
Patients after out-of-hospital cardiac arrest (OHCA) benefit
from therapeutic hypothermia for 12 to 24 hours [1,2]. The
speed with which therapeutic hypothermia is started seems
important for its effect [3,4]. Considering that there is always
a delay in reaching the intensive care unit (ICU), the target
temperature should be reached as soon as possible, prefera-
bly within 30 minutes [5]. Times needed to achieve target tem-
perature with hypothermia (32°C to 34°C) vary widely, from
0.5 to 8 hours or even longer [6]. We encountered a similar
variation in our practice. We hypothesized that the variation of
the time needed to achieve the target temperature was
caused, at least in part, by patient factors such as weight and
fat percentage. Therefore, in the present study, we determined
the relation between body composition and the temperature
course during therapeutic hypothermia. Both anthropometric
and bioelectrical impedance measures were used to estimate
body composition.
CI = confidence interval; ICC = intraclass correlation coefficient; ICU = intensive care unit; OHCA = out-of-hospital cardiac arrest; SD = standard 
deviation; TBF = total body fat.Critical Care    Vol 12 No 4    Jimmink et al.
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Materials and methods
Patients and setting
From May 2006 until June 2007, 27 consecutive OHCA
patients who were eligible for therapeutic hypothermia and
who were admitted to the 28 bed ICU of the Academic Medi-
cal Center, Amsterdam, The Netherlands, were included. The
study protocol was approved by the local institutional review
board, and a signed informed consent form was obtained from
the next of kin for patients eligible for hypothermia. If patients
were capable, they gave informed consent after discharge
from the ICU.
Study design
We conducted a prospective observational study of body
composition by bioimpedance and anthropometrics and tem-
perature profiles during hypothermia.
Inclusion of patients
Comatose survivors after OHCA who were admitted to our
hospital and who were at least 18 years old were included.
Patients eligible for hypothermia but who could not be
weighed by a mattress balance (that is, patients in a prone
position or instable hemodynamically) were excluded from the
study.
The therapeutic hypothermia protocol
Patients were subjected to the hypothermia protocol. On
arrival at the ICU, the patient was placed on a cooling mattress
(Blanket roll 2; Cincinnati Sub-Zero Products, Inc., Cincinnati,
OH, USA), and at the same time, ice-cold lactated Ringer solu-
tions (4°C) were administered with a rate of 100 mL/minute
and a maximum of 30 mL/kg body weight of the patient. Infu-
sions were stopped if the target temperature (32°C to 34°C)
was reached. The induced cooling was maintained by using
this cooling mattress. When the patient reached the tempera-
ture of 34.5°C, the mattress setting was switched from 'man-
ual' to 'auto mode' with a target setting of '33°C'. Temperature
was maintained between 32°C and 34°C for 24 hours. The
mattress in 'auto mode' used a rectal temperature probe for
automatic adjustment of the extent of cooling applied (Blanket
roll 2). We also monitored the continuous nasal temperature
with a probe connected to the bedside monitor (Philips Intelli-
Vue; Philips, Eindhoven, The Netherlands). Patients were
sedated with midazolam and morphine at starting doses of 5
and 2 mg/hour, respectively. All patients were sedated at a
Ramsay score of 6 (no response to glabellar tap or loud noise)
during the period of hypothermia. Shivering was to be
detected by the ICU nurse or the ICU doctor; in case of shiv-
ering, muscle relaxation was achieved with deeper sedation
and/or rocuronium. After reaching the target temperature,
hypothermia was maintained for the next 24 hours, after which
patients were passively warmed to a normal temperature.
Height and weight measurements
Absolute body weight was measured within the first 12 hours
of admission using a mattress balance (Sling-scale 2002;
Scale-Tronix, White Plains, NY, USA) with an accuracy of 0.05
kg. Length was measured with a tape measure.
Impedance measurements
Single-frequency bioimpedance was measured using a Body-
s t a t  1 5 0 0  ( B o d y s t a t  L t d ,  D o u g l a s ,  I s l e  o f  M a n ,  U K ) .  T h i s
impedance measures resistance at a single frequency (50
kHz). Calculations of total body water, fat-free mass, and total
body fat (TBF) are done with regression equations derived
from a resistance index.
Anthropometric measurements
The TBF and total body lean weight were calculated from the
anthropometric measures (Table 1). All measures were per-
formed in triplicate by the researcher (JJJ).
Data collected
We registered the temperature for periods (a) from the start of
active cooling until the target temperature was reached and
(b) from the termination of active cooling until the time at which
the temperature was 36°C. Other data collected were age,
gender, prescribed dosages of rocuronium, length of ICU stay
and length of hospital stay, APACHE II (Acute Physiology and
Chronic Health Evaluation II) score at admission, ICU mortality,
and hospital mortality.
Statistical analysis
Descriptive statistics were used to characterize the study sam-
ple. Intraclass correlation coefficients (ICCs) were used to
assess the concordance between measures of body compo-
sition by impedance and by anthropometrics. The association
between the different body measures (Table 2) and the time
needed to achieve the target temperature is assessed by the
Cox proportional hazards regression analysis. Statistical
uncertainties for differences are expressed by the 95% confi-
dence limits. Data were analyzed with a statistical software
package (SPSS 12.0.1 for Windows; SPSS Inc., Chicago, IL,
USA).
Results
Patients
Twenty-seven consecutive patients admitted to the ICU
between May 2006 and June 2007 participated in the study.
Patient characteristics are shown in Table 3. Twenty out of 27
patients received rocuronium, and the mean dose (standard
deviation, SD) was 104 (82) mg (range 25 to 350 mg).
Impedance and anthropometrics
Body composition measures are presented in Table 2. The
ICC for TBF by impedance [7], TBF by the Durnin and Wom-
ersley [8] tables, TBF by Womersley [9] formula, TBF by
James [10], and TBF by von Döbeln [11] and Deurenberg andAvailable online http://ccforum.com/content/12/4/R87
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colleagues [12] was 0.94 (95% confidence interval [CI] 0.89
to 0.97).
Course of therapeutic hypothermia
The lengths of time needed to achieve temperature targets are
shown in Table 4. Illustrative temperatures during the hypo-
thermia process are shown in Table 5. The mean difference
between the temperatures at admission and at the end of the
active cooling period was 2.1°C. (95% CI 1.6 to 2.6). The
change in temperature toward hypothermia, mean (SD) 2.1°C
(1.1), was smaller compared with the change in temperature
from hypothermia toward normal temperature, mean (SD)
2.9°C (0.8); mean difference 0.8°C (95% CI -1.3 to -0.3).
None of the patients encountered critical events during the
course of therapeutic hypothermia.
Table 1
Anthropometric measures
Measures Conditions
Skin fold thickness (caliper 5 g/mm2)
Triceps and biceps Nondominant side/supine position/between olecranon and acromion
Subscapular Two centimeters below scapula/patient lying on one side
Supra iliac Upper anterior iliac spine
Dimensions
Condylar Breath (sliding caliper)
Bistyloid Breath (sliding caliper)
Waist Circumference of minimum waist (cm)
Hip Circumference of maximum hip (cm)
TBF calculations, percentage
Womersley [9] 33.5 (log Σ 4 skin fold thickness) - 31.1
James [10] Men: 1.1 × weight - (128 × weight2/100 × height2)
Women: 1.07 × weight - 148 × weight2/100 × height2
von Döbeln [11] 15.1 × [(height)2 × (Σ femoral condylar breaths) × (Σ radioulnar breaths)] 0.712
Deurenberg et al. [12] (1.2 × BMI) + (0.23 × age) - (10.8 × gender) - 5.4
BMI, body mass index; TBF, total body fat.
Table 2
Body measures
(n = 27) Mean (SD) Range (minimum-maximum)
Weight, kg 83 (18) 69 (43–112)
Height, cm 174 (10) 39 (150–189)
Body mass index 27 (6) 22 (16–38)
Body surface area, cm2 1.99 (0.25) 1 (1.35–2.35)
TBF by bioimpedance, percentage 26.8 (11.47) 44 (7–51)
TBF by Durnin (table), percentage 27.8 (9.6) 35.5 (12.2–47.7)
TBF by Womersley [9] formula, percentage 25.8 (8.8) 35.1 (6.2–41.3)
TBF by von Doebeln [11], percentage 25.3 (10.6) 35 (4.8–41.1)
TBF by James [10], percentage 26.8 (8.9) 35 (14–49)
TBF by Deurenberg et al. [12], percentage 32.8 (9.8) 38.5 (17.1–55.6)
Waist-to-hip ratio 0.97 (0.092) 0.39 (0.77–1.14)
SD, standard deviation; TBF, total body fat.Critical Care    Vol 12 No 4    Jimmink et al.
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Time to achieve hypothermia
Hazard ratios, corrected for age and gender, for the time to tar-
get temperature were 0.98 (95% CI 0.95 to 1.0; P = 0.07),
0.93 (95% CI 0.85 to 1.0; P = 0.15), and 0.19 (95% CI 0.03
to 1.0; P = 0.06) for body weight, body mass index, and body
surface area, respectively. Hazard ratios, also corrected for
age and gender, for TBF by impedance, TBF by Durnin, and
waist-to-hip ratio were 0.98 (95% CI 0.93 to 1.0; P = 0.42),
0.93 (95% CI 0.87 to 0.99; P = 0.03), and 0.004 (95% CI 0.0
to 6.63; P  = 0.15), respectively. Cooling velocity was not
affected by the use of rocuronium; the drop per hour during
active cooling with the use of rocuronium (n = 20) was median
0.49°C per hour (95% CI 0.10 to 1.01) versus 0.39°C per
hour (95% CI 0.36 to 0.96) without the use (n = 7) of rocuro-
nium (P = 0.83).
Discussion
Only one of the body composition parameters was associated
with the time to achieve target temperature with hypothermia.
TBF (anthropometric by Durnin's table) showed a significant
but slight increase in the time needed to achieve target tem-
perature if TBF increases. As none of the other highly concord-
ant measurements showed a relationship with the
achievement of the target temperature, the association might
have no clinical relevance. From our data, we cannot justify the
adjustment of cooling practice solely based on body composi-
tion. Considering the time needed to reach the target temper-
ature, additional research into other factors is necessary.
According to Polderman [13], younger patients react earlier
and with greater intensity and effectiveness to changes in
body temperature than older patients. Polderman also implies
that the surface cooling of obese patients will be more difficult
and require significantly more time to achieve the target tem-
perature. We could not confirm these hypotheses. Maybe
because the ice-cold fluid infusion is administered by (esti-
mated) body weight, the effect of the insulated properties of
fat is less important than when cooling is done by surface cool-
ing only. It seems reasonable, though, that the influence of
body composition is higher when only external cooling tech-
niques are used rather than internal cooling techniques. How-
ever, since a combination of internal and external methods was
used in the present study, we are not able to answer this ques-
tion.
The use of rocuronium reduces shivering and, therefore, cool-
ing velocity may be increased with its use. There was, how-
ever, no difference in cooling velocity between patients who
did receive rocuronium and those who did not. Also, patients
not receiving rocuronium might have subclinical shivering,
which can be detected only by electromyography, and there-
fore these patients have a reduced cooling velocity. Since we
did not perform electromyography in our patients, we cannot
confirm this hypothesis in our study.
Bernard and colleagues [14] succeeded in decreasing body
temperature from 35.5°C to 33.8°C within 30 minutes. That is
a temperature drop of 3.4°C per hour. Only one patient within
our series met this criterion. In this particular study, patient
characteristics such as weight and body composition were not
mentioned. It is important to acknowledge that the main limita-
tion of this study is the small sample size and subsequent lack
Table 3
Baseline characteristics of patients
Patients included 27
Male, percentage (number of males/total number of 
patients)
78% (21/27)
Age in years, mean (standard deviation) 60 (13)
APACHE II score, mean (standard deviation) 23 (7.8)
Length of stay in intensive care unit in hours, median 
(interquartile range)
112 (59–158)
In-hospital mortality, percentage (number of deaths/
total number of patients)
52% (14/27)
APACHE, Acute Physiology and Chronic Health Evaluation.
Table 4
Different periods during the cooling process
Time periods/duration (n = 27) Minutes
Time from admission to start of cooling 41 (16–76)
Time from admission to target temperature 191 (105–382)
Duration of active cooling 1,525 (1,432–1,740)
Time from start of cooling to target 
temperature
152 (64–275)
Time from termination of active cooling to 
temperature of ≥ 36°C
840 (514–1,080)
All values are expressed as median (interquartile range).
Table 5
Temperature profile of cooled patients (n = 27)
Degrees Celsius
Temperature at start of cooling, mean (SD) 35.3 (1.05)
Temperature drop per hour during active cooling, 
median (IQr)
0.5 (0.11–1.0)
Minimum temperature during active cooling, 
mean (SD)
31.8 (0.74)
Maximum temperature during active cooling, 
mean (SD)
34.4 (0.40)
Temperature at termination of active cooling, 
mean (SD)
33.1 (0.75)
Temperature rise per hour after termination of 
active cooling, median (IQr)
0.21 (0.16–0.33)
Total temperature rise until normal temperature 
(36°C), mean (SD)
2.9 (0.75)
IQr, interquartile range; SD, standard deviation.Available online http://ccforum.com/content/12/4/R87
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of power. This is due mainly to the length of time it took to
recruit patients into the study.
Conclusion
The time to reach target temperature seems not to be influ-
enced (or at most only partly) by body composition. There
might be other factors like systemic vascular resistance, basic
metabolism, shivering, or other factors of influence that cannot
be measured within this study but should be subjected to fur-
ther research.
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Key messages
￿  From our data, we cannot justify the adjustment of cool-
ing practice solely based on body composition.
￿  Time to reach target temperature seems not to be influ-
enced (or at most only partly) by body composition.